ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed Mar 31, 2026 · 10-K · 90 days after period end · 0001493152-26-014271
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$678.57K | -$1.42M | -$13.34M | -$12.25M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end
